Immuron limited announces participation in the ld micro main event xvi

Presentation on wednesday, october 4th at 11:00 pt melbourne, australia--(newsfile corp. - september 18, 2023) - immuron limited (nasdaq: imrn), an australian based and globally integrated biopharmaceutical company, announced today that it will be presenting at the 16th annual main event on wednesday, october 4th at 11:00 pt at the luxe sunset boulevard hotel. steven lydeamore, ceo, will be giving the presentation.
IMRN Ratings Summary
IMRN Quant Ranking